TP53 and hepatocellular carcinoma: TP53 mutation frequency was evidently higher in high-risk group (frequency rate 42%) than low-risk group (frequency rate 14%) according to our mutation results, suggesting more increases genomic instability and complicated major pathway signaling changes in HCC.